COMMUNIQUÉS West-GlobeNewswire

BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
28/04/2026
LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- via IBN — BioAdaptives, Inc. (OTC: BDPT) today announced the official launch of MyndSystem™ and website. MyndSystem™ was originally developed for professional fighters. We [...]
NBPure Launches Exclusive MagO7 60-Count at Walmart, Expanding Access to Its Best-Selling Gut Cleanse
28/04/2026
PHOENIX, April 28, 2026 (GLOBE NEWSWIRE) -- NBPure, a trusted leader in gut-first wellness for more than 28 years, today announced the launch of its flagship MagO7 cleanse at Walmart stores, a significant step in [...]
Invitation to the presentation of ALK’s first quarter 2026 results on Tuesday, 5 May 2026
28/04/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first quarter of 2026 in the morning on Tuesday, 5 May 2026. Later on the same day, the company will host a presentation for investors and [...]
Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026
28/04/2026
Oslo, Norway, 28 April 2026 Vistin Pharma ASA (OSE: VISTN); please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 20 May 2026 at 13:00 CEST. It will not be possible with physical [...]
Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation
28/04/2026
Contribution will support multi-stakeholder efforts to strengthen the use of patient experience data in healthcare decision-making FRAMINGHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Alira Health today announced its [...]
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
28/04/2026
Publication reports statistically significant improvement in sleep quality following treatment with Nexalin’s 15 mA, 77.5 Hz stimulation approach, with no meaningful improvement in the sham group Neuroimaging data [...]
Clariane annonce le succès de son offre de 230 millions d’euros d’obligations senior additionnelles
28/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System
28/04/2026
Latest authorization expands MiniMed CGM portfolio in Canada BRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE) -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health [...]
Axe Compute to Present at the Market Movers Investor Summit and the D. Boral Capital 2026 Global Conference
28/04/2026
CEO Chris Miglino to deliver the Company's presentation at the Market Movers Investor Summit on Tuesday, May 5, 2026, at 9:20 a.m. ET — covering Axe Compute's enterprise GPU compute platform, infrastructure scale across [...]
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
28/04/2026
Emergent’s Canton facility will manufacture drug substance and obtains exclusive distribution rights GAITHERSBURG, Md. and GENEVA, April 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today [...]
Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology
28/04/2026
BURLINGAME, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately-held biotechnology company advancing next-generation antibody architectures, today announced that the United States Patent [...]
BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures
28/04/2026
SUNNYVALE, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]
electroCore to Present at the Market Movers Investor Summit on May 5, 2026
28/04/2026
ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the Market Movers [...]
Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies
28/04/2026
Kestrel has entered into a warrant agreement with AbbVie with an exclusive option for AbbVie to acquire the Company based on defined development milestones WATERTOWN, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Kestrel [...]
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
28/04/2026
SEATTLE, April 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended [...]
Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics
28/04/2026
Vienna, Austria, April 28, 2026 (GLOBE NEWSWIRE) -- Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types Vienna, Austria, April 28, 2026 – Proxygen, a [...]
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
28/04/2026
The Company will Host a Conference Call and Webcast on May 12, 2026, at 8:30 AM ET CORAL GABLES, Fla., April 28, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a [...]
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
28/04/2026
Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per batch that is among the lowest in the industry Initial translational data [...]
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
28/04/2026
Buntanetap improved cognition in pTau217-positive early AD patients The drug reduced neurotoxic proteins as well as biomarkers of neuroinflammation and neurodegeneration Buntanetap was safe and well-tolerated, including [...]

Pages